Literature DB >> 23001217

Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis.

Mariella Errede1, Francesco Girolamo, Giovanni Ferrara, Maurizio Strippoli, Sara Morando, Valentina Boldrin, Marco Rizzi, Antonio Uccelli, Roberto Perris, Caterina Bendotti, Mario Salmona, Luisa Roncali, Daniela Virgintino.   

Abstract

The pathophysiology of cerebral cortical lesions in multiple sclerosis (MS) is not understood. We investigated cerebral cortex microvessels during immune-mediated demyelination in the MS model chronic murine experimental autoimmune encephalomyelitis (EAE) by immunolocalization of the endothelial cell tight junction (TJ) integral proteins claudin-5 and occludin, a structural protein of caveolae, caveolin-1, and the blood-brain barrier-specific endothelial transporter, Glut 1. In EAE-affected mice, there were areas of extensive subpial demyelination and well-demarcated lesions that extended to deeper cortical layers. Activation of microglia and absence of perivascular inflammatory infiltrates were common in these areas. Microvascular endothelial cells showed increased expression of caveolin-1 and a coincident loss of both claudin-5 and occludin normal junctional staining patterns. At a very early disease stage, claudin-5 molecules tended to cluster and form vacuoles that were also Glut 1 positive; the initially preserved occludin pattern became diffusely cytoplasmic at more advanced stages. Possible internalization of claudin-5 on TJ dismantling was suggested by its coexpression with the autophagosomal marker MAP1LC3A. Loss of TJ integrity was confirmed by fluorescein isothiocyanate-dextran experiments that showed leakage of the tracer into the perivascular neuropil. These observations indicate that, in the cerebral cortex of EAE-affected mice, there is a microvascular disease that differentially targets claudin-5 and occludin during ongoing demyelination despite only minimal inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001217     DOI: 10.1097/NEN.0b013e31826ac110

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  32 in total

1.  ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9.

Authors:  Minghua Zheng; Junjie Wei; Yulan Tang; Chengcheng Yang; Yunfei Wei; Xiaoduan Yin; Qianqian Liu
Journal:  J Mol Neurosci       Date:  2014-05-01       Impact factor: 3.444

2.  Regulation of Endothelial Permeability in the Corpus Luteum: A Review of the Literature.

Authors:  D Herr; I Bekes; C Wulff
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-11       Impact factor: 2.915

3.  Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.

Authors:  Tobias V Lanz; Simon Becker; Matthias Osswald; Stefan Bittner; Michael K Schuhmann; Christiane A Opitz; Sadanand Gaikwad; Benedikt Wiestler; Ulrike M Litzenburger; Felix Sahm; Martina Ott; Simeon Iwantscheff; Carl Grabitz; Michel Mittelbronn; Andreas von Deimling; Frank Winkler; Sven G Meuth; Wolfgang Wick; Michael Platten
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

4.  Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation.

Authors:  Mojdeh Abbasi; Vivek K Gupta; Nitin Chitranshi; Veer B Gupta; Mehdi Mirzaei; Yogita Dheer; Linda Garthwaite; Thiri Zaw; Robert G Parton; Yuyi You; Stuart L Graham
Journal:  Mol Neurobiol       Date:  2020-06-23       Impact factor: 5.590

5.  Magnolol prevented brain injury through the modulation of Nrf2-dependent oxidative stress and apoptosis in PLP-induced mouse model of multiple sclerosis.

Authors:  Tehmina Bibi; Adnan Khan; Ashraf Ullah Khan; Bushra Shal; Hussain Ali; Eun Kyoung Seo; Salman Khan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-03-29       Impact factor: 3.000

6.  More than hypomyelination in Pol-III disorder.

Authors:  Adeline Vanderver; Davide Tonduti; Genevieve Bernard; Jinping Lai; Christopher Rossi; Giovanni Carosso; Martha Quezado; Kondi Wong; Raphael Schiffmann
Journal:  J Neuropathol Exp Neurol       Date:  2013-01       Impact factor: 3.685

7.  Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.

Authors:  Debayon Paul; Ann E Cowan; Shujun Ge; Joel S Pachter
Journal:  Microvasc Res       Date:  2012-12-20       Impact factor: 3.514

Review 8.  Barrier function in the peripheral and central nervous system-a review.

Authors:  A K Reinhold; H L Rittner
Journal:  Pflugers Arch       Date:  2016-12-12       Impact factor: 3.657

9.  Vascular and immunopathological role of Asymmetric Dimethylarginine (ADMA) in Experimental Autoimmune Encephalomyelitis.

Authors:  Inderjit Singh; Judong Kim; Nishant Saxena; Seungho Choi; S M Touhidul Islam; Avtar K Singh; Mushfiquddin Khan; Jeseong Won
Journal:  Immunology       Date:  2021-08-02       Impact factor: 7.397

10.  The Impact of Fixation on the Detection of Oligodendrocyte Precursor Cell Morphology and Vascular Associations.

Authors:  Friederike Pfeiffer; Amin Sherafat; Akiko Nishiyama
Journal:  Cells       Date:  2021-05-24       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.